Please do not adjust margins
New Journal of Chemistry
Page 4 of 5
DOI: 10.1039/C8NJ02109K
COMMUNICATION
Journal Name
Anelli, M. Brocchetta, E. Cappelletti, A. Ferraris, V.
Vincenzi, Open Org. Chem. J., 2009, 3, 35–41.
2. C. M. Holden, M. F. Greaney Chem. Eur. J., 2017, 23, 8992 –
9008.
3. (a) B. Sreedhar, R. Arundhathi, M. A. Reddy and M. L.
Kantam, Synthesis, 2009, 483–487; (b) L. El Kaïm, L.
Grimaud and J. Oble, Angew. Chem. Int. Ed., 2005, 44,
7961–7964; (c) M. Mizuno and M. Yamano, Org. Lett.,
2005, 7, 3629–3631.
4. J. Weidner, P. M. Weintraub, R. A. Schnettler and N. P.
Peet, Tetrahedron, 1997, 53, 6303–6312.
5. T. J. Snape, Chem. Soc. Rev., 2008, 37, 2452–2458.
6. C. Bonini, G. Cristiani, M. Funicello and L. Viggiani,
Synth. Commun., 2006, 36, 1983–1990
7. Y. S. Xie, B. V. D. Vijaykumar, K. Jang, K. M. Choi, H.
Zuo, Y. J. Yoon, D. S. Shin, Bull. Korean Chem. Soc.,
2013, 34, 3881–3884.
8. C. Bonini, M. Funicello, R. Scialpi, P. Spagnolo,
Tetrahedron, 2003, 59, 7515–7520.
Scheme 4. Competitive study.
Based on the literature precedents15ꢀ16 and our experimental
observations, a plausible mechanism is showed in Scheme 5.
Initially, Oꢀaryl coumarin (3) formed by nucleophilic substitution
participates in cyclization (via azaꢀMichael addition) results in the
formation of spiro intermediate and subsequent cleavage of the
9. (a) R. O’Kennedy, R. Zhorenes, Coumarins: Biology,
Applications, Mode of Action, Wiley, Chichester, 1997;
for reviews, see: (b) J. R. S. Hoult, M. Paya, Gen.
Pharmacol., 1996, 27, 713–722; (c) D. L. Yu, M.
Suzuki, L. Xie, S. L. Morrisꢀ Natschke, K. H. Lee, Med.
Res. Rev., 2003, 23, 322–345; (d) K. C. Fylaktakidou, D.
J. HadjipavlouꢀLitina, K. E. Litines, D. N. Nicolaides,
Curr. Pharm. Des., 2004, 10, 3813–3833; (e) F. Borges,
F. Roleira, N. Mihazes, L. Santana, E. Uriarte, Curr.
Med. Chem., 2005, 12, 887–916; (f ) X. S. Zhang, Z. W.
Li, Z. ꢀJ. Shi, Org. Chem. Front., 2014, 1, 44–49.
10. D. Cao, Y. Liu, W. Yan, C. Wang, P. Bai, T. Wang, M.
Tang, X. Wang, Z. Yang, B. Ma, L. Ma, L. Lei, F.
Wang, B. Xu, Y. Zhou, T. Yang, L. Chen, J. Med.
Chem., 2016, 59, 5721−5739.
weaker C−O forms
a new CꢀN bond give to Nꢀaryl
coumarin/pyran 4.
11. T. Balalas, A. A. Sada, D. J. H. Litina, K. E. Litinas,
Synthesis, 2017, 49, 2575ꢀ2583.
12. (a) M. H. Chen, B. C. Tang, X. Zhang, H. Shu, J.
Heterocyclic Chem., 54, 2017, 1186–1192 (b) M. H.
Chen1, D. W. Lu1, X. Zhang1, Z. Y. Zhou1, X. B.
Wang, H. Shu, Chem. Pap., 2017, 71, 1579–1586.
Scheme 5. Plausible mechanism.
In conclusion, a novel methodology has been developed via
K2CO3 mediated CꢀN bond formation leading to form new
coumarin/pyran derivatives via smiles rearrangement. This
methodology involvesthe reaction of 4ꢀbromo coumarin/pyran
reacts with 2ꢀamino phenols to form Oꢀarylated product and
subsequently rearrange into Nꢀarylated product. The amount of
K2CO3 plays important role to generate the Oꢀ or Nꢀarylated
products.The present methodology is a selective, straightforward
and mild reaction conditions for synthesis of a range of Nꢀarylated
coumarins/pyrans.
13. (a) K. S. Kumar, S. R. Meesa, B. Rajesham, B. Bhasker,
M. A. Ashfaq, A. A. Khan, S. S. Rao, M. Pal, RSC Adv.,
2016, 6, 48324–48328; (b) K. S. Kumar, B. Bhaskar, M.
S. Ramulu, N. P. Kumar, M. A. Ashfaq, M. Pal, Org.
Biomol. Chem., 2017, 15, 82–87; (c) K. S. Kumar, M. S.
Ramulu, B. Rajesham, N. P. Kumar, V. Voora, R. K.
Kancha, Org. Biomol. Chem., 2017, 15, 4468ꢀ4476.
14. Crystal data of (7): CCDC 1825038, Single crystals
suitable for Xꢀray diffraction of 7 DCM: EtOAc (1:1).
Molecular formula = C11 H11 N1 O3, Formula weight =
205.21, Crystal system = Triclinic, space group = P ꢀ1, a
= 8.0084(3) Å, b = 8.1626(3) Å, c = 8.5962(3) Å, V =
465.51(3) Å3, T = 296(2) K, Z = 2, Dc = 1.464 Mg/m3,
7164 Reflections collected, 1801 [R(int) = 0.0751]
independent reflections, Goodness of fit = 1.066.
KSK thanks the University Grants Commission (UGC), New
Delhi, for the award of an Assistant Professorship under FRP and
CSIR, India, for the financial support [02(0234)/15/EMRꢀII].
Conflicts of interest
The authors confirm that this article content has no conflict
of interest.
15. L.
J. Meng, H. Zuo, B.
V.
Notes and references
D. Vijaykumar, D. Gautam, K.
M. Choi, K. Jang, Y.
1. (a) L. E. Overman, Tetrahedron, 2009, 65, 6432–6446;
(b) A. R. Katritzky, A. F. Pozharskii, Handbook of
Heterocyclic Chemistry, 2nd ed.; Pergamon Press:
Oxford, 2000; (c) J. Nowicki, Molecules, 2000, 5, 1033–
1050; (d) A. Commarieu, W. Hoelderich, J. A. Laffitte,
M. ꢀP Dupont, J. Mol. Catal. A: Chem., 2002, 137,
182−183; (e) G. Dahlhoff, J. P. M. Niederer, W. F.
Hoelderich, Catal. Rev., 2001, 43, 381–441; (f) P. L.
J. Yoon, D. S. Shin, Bull. Korean Chem. Soc., 2013, 34,
585ꢀ589.
16. D. Ameen, T. J. Snape, Eur. J. Org. Chem., 2014, 1925–
1934.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins